Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.

Autor: de Calbiac O; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes and Angers, Saint-Herblain, France., Lusque A; Department of Biostatistics, Institut Claudius Regaud-IUCT Oncopole, Toulouse, France., Mailliez A; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Uwer L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France., Emile G; Department of Medical Oncology, Centre François Baclesse, Caen, France., Jouannaud C; Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Patsouris A; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes and Angers, Angers, France., Diéras V; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Leheurteur M; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France., Cottu P; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., D'Hondt V; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France., Desmoulins I; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Mourato-Ribeiro J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Martin AL; Health Data and Partnerships Department, Unicancer, Paris, France., Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes and Angers, Saint-Herblain, France.

Publikováno v: JAMA network open [JAMA Netw Open] 2022 Sep 01; Vol. 5 (9), pp. e2231170. Date of Electronic Publication: 2022 Sep 01.

Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies.

Autor: Tommasi, Chiara^1,2,3 (AUTHOR) chiara.tommasi@unipr.it, Airò, Giulia^1,2,3 (AUTHOR) fabiana.prattico@unipr.it, Pratticò, Fabiana^1,2,3 (AUTHOR) irene.testi@unipr.it, Testi, Irene^1,2 (AUTHOR) matilde.coriano@unipr.it, Corianò, Matilde^1,2,3 (AUTHOR) benedetta.pellegrino@unipr.it, Pellegrino, Benedetta^1,3 (AUTHOR), Denaro, Nerina⁴ (AUTHOR), Demurtas, Laura⁵ (AUTHOR) czsolinas@gmail.com, Dessì, Mariele⁵ (AUTHOR), Murgia, Sara⁶ (AUTHOR), Mura, Giovanni⁷ (AUTHOR), Wekking, Demi⁸ (AUTHOR), Scartozzi, Mario^5,6 (AUTHOR), Musolino, Antonino^1,2,3 (AUTHOR) chiara.tommasi@unipr.it, Solinas, Cinzia⁵ (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 7, p1873. 20p.

Therapeutic Immunomodulation in Gastric Cancer.

Autor: Akkanapally, Venu¹ (AUTHOR) venu.akkanapally@osumc.edu, Bai, Xue-Feng^1,2 (AUTHOR) xue-feng.bai@osumc.edu, Basu, Sujit^1,2,3 (AUTHOR) sujit.basu@osumc.edu

Publikováno v: Cancers. Feb2024, Vol. 16 Issue 3, p560. 17p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?

Autor: Popović, Marina^1,2 (AUTHOR) mpopovi1@kbc-zagreb.hr, Silovski, Tajana¹ (AUTHOR), Križić, Marija¹ (AUTHOR), Dedić Plavetić, Natalija^1,2 (AUTHOR) mpopovi1@kbc-zagreb.hr

Publikováno v: International Journal of Molecular Sciences. May2023, Vol. 24 Issue 9, p8206. 16p.